Stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. Over 100 issued patents support the Stereotaxis platform. The core components of Stereotaxis’ systems have received regulatory clearance in the United States, European Union, Japan, Canada, China, and elsewhere. For more information, please visit www.stereotaxis.com.
Location: United States, Missouri, Saint Louis
Employees: 51-200
Phone: +1 314-678-6100
Founded date: 1990
Investors 2
| Date | Name | Website |
| - | Ascension ... | ascensionv... |
| - | UVA Licens... | lvg.virgin... |
Mentions in press and media 12
| Date | Title | Description |
| 02.10.2024 | ROTH to Host 3rd Annual Healthcare Opportunities Conference on October 9 in New York City | Conference to Feature Leading Healthcare Companies and Institutional Investors for 1x1/Small Group Meetings and Panels NEW YORK, Oct. 02, 2024 (GLOBE NEWSWIRE) -- via IBN -- ROTH Capital Partners, LLC (“ROTH”), www.roth.com, is pleased to a... |
| 04.03.2024 | Stereotaxis Announces Regulatory Submissions of the MAGiC Ablation Catheter in Europe and the United States | ST. LOUIS, March 04, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that regulatory submissions were made recently in bot... |
| 04.03.2024 | Stereotaxis Reports 2023 Full Year Financial Results | ST. LOUIS, March 04, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the fourth quarter and full year... |
| 09.08.2022 | Stereotaxis Reports 2022 Second Quarter Financial Results | ST. LOUIS, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the second quarter ended June 30,... |
| 09.03.2022 | Stereotaxis Announces Grand Opening of New Global Headquarters in St. Louis | ST. LOUIS, March 09, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today is holding the grand opening of its new, 45,000-square-foot glo... |
| 30.08.2021 | Stereotaxis and MicroPort EP Collaborate to Advance Innovation and Adoption of Robotic Electrophysiology in China | ST. LOUIS and SHANGHAI, China, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Shanghai Microport EP Medtech Co., Ltd. (“MicroPort EP”) today announced a broad collaboration to advance technology innovation and commercial ado... |
| 27.02.2013 | The Rise of Robotics in Med Tech | Robots represent a vision of the future, a vision that inspires two parts amazement and one part fear of being replaced by superior machines. In manufacturing, robots have been deployed since the 1960’s to exceed human precision and product... |
| 16.02.2012 | Edwards lands CE Mark for Intuity valve | Regulatory Roundup | Edwards Lifesciences Corp. (NYSE:EW) landed CE Mark approval in the European Union for its Intuity valve system. The Intuity valve, made of bovine pericardial tissue, is a minimally invasive option for patients in need of aortic valve repla... |
| 25.02.2010 | Stereotaxis narrows losses in 2009 | Stereotaxis Inc. (NSDQ:STXS) reported strong fourth-quarter and year-end sales, helping the company narrow losses nearly 38 percent in 2009. The St. Louis, Mo.-based cardiology instrument control system maker reported a net loss of $6.7 mil... |
| 04.05.2009 | Akron General ushers in era of caring for hearts with remote robotic technology | The doctors and their teams work on patients from outside the procedure room, using computer screens and digital automation. This remote work minimizes X-ray exposure for both patient and medical staff, the hospital said. “This Stereotaxis... |
Show more